Patient Advocates Continue To Push US FDA For Central Office
Executive Summary
Will a meeting with the agency's new principal deputy commissioner help assure creation of new access point for patient engagement?
You may also be interested in...
US FDA Is Dedicating A 'Patient Affairs' Staff Without A Formal Reorg
The agency's principle deputy commissioner says it's creating a patient affairs staff, but will not undergo a reorganization.
US FDA's Patient Affairs Office Is An Office … In Spirit
Rachel Sherman says agency is creating patient affairs staff, but will not undergo reorganization to create an official office.
US FDA's Centralized Patient Affairs Office Aims For No Disruption
New office will develop agency-wide patient engagement policy and serve as entry point for patient groups new to FDA, but will not interfere with existing relationships between advocates and the drugs and biologics centers, FDA Commissioner Gottlieb says.